Jilin Aodong Medicine Industry (Group) Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jilin Aodong Medicine Industry (Group) Co., Ltd. with three other
companies in this sector in CHINA :
Dong-E-E-Jiao Co Ltd
sales of 2.96 billion Chinese Renmimbi [US$415.29 million]
of which 70%
was Pharmaceutical industry),
Jiuzhitang Company Limited
(3.18 billion Chinese Renmimbi [US$446.19 million]
of which 88%
was Pharmacuetical Industry), and
Zhejiang Hisoar Pharmaceutical Co. Ltd
(2.94 billion Chinese Renmimbi [US$412.24 million]
of which 55%
was Pharmatheutical Industry).
Jilin Aodong Medicine Industry (Group) Co., Ltd. reported sales of 3.09 billion Chinese Renmimbi (US$432.81 million)
December of 2019.
decrease of 7.1%
versus 2018, when the company's sales were 3.32 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 24.9% decline
in Other Business, from 9.30 million Chinese Renmimbi to 6.99 million Chinese Renmimbi.
There were also decreases in sales in
Pharmaceutical Manufacturing (down 8.6% to 2.90 billion Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Food (up 31.8% to 131.05 million Chinese Renmimbi)
Other (up 17.6% to 53.30 million Chinese Renmimbi)